Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-14 Sale | 2022-02-14 9:10 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development | 601 | $50.23 | $30,188 | 40,212 (Direct) | View |
| 2022-01-18 Sale | 2022-01-20 7:15 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development | 30,000 | $61.36 | $1,840,745 | 411,097 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-10 Option Award | 2022-02-14 9:10 pm | N/A 2032-02-09 | Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development | 34,563 | $0 | 40,212 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 7:15 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development | 30,000 | $18 | 411,097 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 7:15 pm | N/A 2030-03-25 | Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development | 30,000 | $0 | 411,097 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 7:01 pm | N/A 2031-02-10 | Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2020-04-03 6:11 pm | N/A 2030-03-25 | Zentalis Pharmaceuticals LLC | ZNTL | Voliotis Dimitris SVP, Clinical Development | 0 | $0 | 154,949 (Direct) | View |